Calendar
Improving Treatment Predictions in Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a cancer of the blood and bone marrow. About 30%
New Therapy Offers Hope for Clear Cell Gynaecological Cancers
The LARA trial, led by Assoc Prof David Tan and Dr Natalie Ngoi, marks a
A Gene Switch that Fuels Myeloma Growth
Multiple myeloma is a type of blood cancer that affects plasma cells, a kind of
Uncovering an Aggressive Form of Liver Cancer
Intrahepatic cholangiocarcinoma (ICC) is a fast-growing cancer that starts in the bile ducts inside the
Targeting CD47 – Unlocking an Alternative Cell Death Pathway in Blood Cancer Treatment
A recent study has uncovered that blocking the immune checkpoint protein CD47, long recognised for
Recharging the Aging Brain: DMTF1 to the Rescue
As we age, stem cells in the brain — responsible for repair and renewal—become less
director's foreword
Bringing N2CR to Greater Heights
The National University of Singapore’s Centre for Cancer Research (N2CR) was established in 2020 as one of ten Translational Research Programmes under the Yong Loo Lin School of Medicine. As the largest of these programmes, N2CR brings together more than 100 faculty members spanning basic, translational, and clinical sciences — united by a shared vision to advance cancer research and improve patient outcomes.
Professor Goh Boon Cher
Director, NUS Centre for Cancer Research (N2CR)
Translational Research Programme, Yong Loo Lin School of Medicine
National University of Singapore
OUR VISION AND MISSION
of the N2CR is simple
To develop innovative new ways to detect, cure or prevent cancer.
The hallmark of
The Programme
SCOUT
– Decoding Cancer’s Beginnings for Healthier Tomorrow
Theme Leads
Dr OOI Gaik Ming, Melissa
Dr CHEOK Chit Fang
COMPASS
– Charting the Future of Precision Oncology
The COMPASS theme unites a diverse community of basic and clinical cancer scientists to advance customised oncology. By integrating molecular profiling for strategic patient selection and enabling technologies for new treatment modalities, COMPASS builds a collaborative platform to discover mechanisms, refine therapies and accelerate precision medicine with a focus on Asian-specific tumour types.
Theme Leads
Dr TAY Kai Xun, Joshua
Dr Dennis KAPPEI
some of our trending
News & Events
Discover what matters to you the most.
Giving
Your Gift, Our Breakthroughs
Your generosity fuels our mission to advance cancer research and nurture future scientists. By giving to N2CR, you drive discoveries, support researchers, and strengthen collaborations that bring us closer to better treatments. Every gift, no matter the size, makes a meaningful impact in the fight against cancer.
be part of us
Find The Best Positions For You
Join us and be a part in shaping Singapore's healthcare for the future!